Filing Details
- Accession Number:
- 0001437749-22-028468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-05 20:06:09
- Reporting Period:
- 2022-12-01
- Accepted Time:
- 2022-12-05 20:06:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1158895 | Lemaitre Vascular Inc | LMAT | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1366346 | J Lawrence Jasinski | C/O Lemaitre Vascular, Inc. 63 Second Avenue Burlington MA 01803 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-02 | 2,500 | $23.56 | 11,409 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 2,500 | $35.48 | 13,909 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-12-02 | 5,000 | $37.29 | 18,909 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-02 | 10,000 | $47.07 | 8,909 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Dividend Equivalent Rights | Acquisiton | 2022-12-01 | 2 | $0.00 | 2 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-02 | 2,500 | $0.00 | 2,500 | $23.56 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-02 | 2,500 | $0.00 | 2,500 | $35.48 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-12-02 | 5,000 | $0.00 | 5,000 | $37.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5 | No | 4 | A | Direct | ||
| 0 | 2018-12-19 | 2023-12-19 | No | 4 | M | Direct |
| 2,500 | 2019-12-20 | 2024-12-20 | No | 4 | M | Direct |
| 2,500 | 2020-12-02 | 2025-12-02 | No | 4 | M | Direct |
Footnotes
- Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $47.00 to $47.23. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
- This option is fully vested and exercisable.
- This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.
Billionaire Hedge Funds
